Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

EMERGENT BIOSOLUTIONS INC. Increase (Decrease) in Prepaid Expense and Other Assets

EMERGENT BIOSOLUTIONS INC. (EBS) reported Increase (Decrease) in Prepaid Expense and Other Assets of $600.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06

  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $100.00K.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $500.00K.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $15.40M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $2.10M, a 84.67% decline year-over-year.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$11.70M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$169.90M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$11.70M, a 158.79% decline from fiscal 2022.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $19.90M.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$100.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$600.00K
10-Q · filed 2026-08-06
$16.00M
derived: sum of 3 quarters · filed 2026-08-06
$18.10M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$500.00K
10-Q · filed 2026-05-01
$15.90M
derived: sum of 2 quarters · filed 2026-05-01
$18.00M
derived: sum of 3 quarters · filed 2026-05-01
-$1.70M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$15.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$17.50M
derived: sum of 2 quarters · filed 2026-02-27
-$2.20M
derived: sum of 3 quarters · filed 2026-08-06
-$11.70M
10-K · filed 2026-02-27
2025-09-30$2.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$17.60M
derived: sum of 2 quarters · filed 2026-08-06
-$27.10M
10-Q · filed 2025-10-30
-$50.70M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$19.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$29.20M
10-Q · filed 2026-08-06
-$52.80M
derived: sum of 3 quarters · filed 2026-08-06
-$39.10M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$9.50M
10-Q · filed 2026-05-01
-$33.10M
derived: sum of 2 quarters · filed 2026-05-01
-$19.40M
derived: sum of 3 quarters · filed 2026-05-01
-$185.40M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31-$23.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$9.90M
derived: sum of 2 quarters · filed 2026-02-27
-$175.90M
derived: sum of 3 quarters · filed 2026-02-27
-$169.90M
10-K · filed 2026-02-27
2024-09-30$13.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$152.30M
derived: sum of 2 quarters · filed 2025-10-30
-$146.30M
10-Q · filed 2025-10-30
-$176.30M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30-$166.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$160.00M
10-Q · filed 2025-08-07
-$190.00M
derived: sum of 3 quarters · filed 2026-02-27
-$189.50M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$6.00M
10-Q · filed 2025-05-08
-$24.00M
derived: sum of 2 quarters · filed 2026-02-27
-$23.50M
derived: sum of 3 quarters · filed 2026-02-27
-$10.20M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$30.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$29.50M
derived: sum of 2 quarters · filed 2026-02-27
-$16.20M
derived: sum of 3 quarters · filed 2026-02-27
-$11.70M
10-K · filed 2026-02-27
2023-09-30$500.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$13.80M
derived: sum of 2 quarters · filed 2024-11-07
$18.30M
10-Q · filed 2024-11-07
$3.90M
derived: sum of 4 quarters · filed 2025-03-04
2023-06-30$13.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$17.80M
10-Q · filed 2024-08-07
$3.40M
derived: sum of 3 quarters · filed 2025-03-04
$18.30M
derived: sum of 4 quarters · filed 2025-03-04
2023-03-31$4.50M
10-Q · filed 2024-05-02
-$9.90M
derived: sum of 2 quarters · filed 2025-03-04
$5.00M
derived: sum of 3 quarters · filed 2025-03-04
$7.80M
derived: sum of 4 quarters · filed 2025-03-04
2022-12-31-$14.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
$500.00K
derived: sum of 2 quarters · filed 2025-03-04
$3.30M
derived: sum of 3 quarters · filed 2025-03-04
$19.90M
10-K · filed 2025-03-04
2022-09-30$14.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11
$17.70M
derived: sum of 2 quarters · filed 2023-12-11
$34.30M
10-Q · filed 2023-12-11
$29.20M
10-Q · filed 2022-11-09
-$28.20M
derived: sum of 4 quarters · filed 2024-03-08
2022-06-30$2.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$19.40M
10-Q · filed 2023-08-09
-$43.10M
derived: sum of 3 quarters · filed 2024-03-08
$9.30M
derived: sum of 4 quarters · filed 2024-03-08
2022-03-31$16.60M
10-Q · filed 2023-05-10
-$45.90M
derived: sum of 2 quarters · filed 2024-03-08
$6.50M
derived: sum of 3 quarters · filed 2024-03-08
-$1.10M
derived: sum of 4 quarters · filed 2024-03-08
2021-12-31-$62.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
-$10.10M
derived: sum of 2 quarters · filed 2024-03-08
-$17.70M
derived: sum of 3 quarters · filed 2024-03-08
-$7.70M
10-K · filed 2024-03-08
$24.70M
10-K · filed 2022-02-25
2021-09-30$52.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$44.80M
derived: sum of 2 quarters · filed 2022-11-09
$54.80M
10-Q · filed 2022-11-09
$19.90M
derived: sum of 4 quarters · filed 2023-12-11
2021-06-30-$7.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$2.40M
10-Q · filed 2022-08-02
-$32.50M
derived: sum of 3 quarters · filed 2023-12-11
$12.40M
derived: sum of 4 quarters · filed 2023-12-11
2021-03-31$10.00M
10-Q · filed 2022-04-29
-$24.90M
derived: sum of 2 quarters · filed 2023-12-11
$20.00M
derived: sum of 3 quarters · filed 2023-12-11
$21.60M
derived: sum of 4 quarters · filed 2023-12-11
2020-12-31-$34.90M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11
$10.00M
derived: sum of 2 quarters · filed 2023-12-11
$11.60M
derived: sum of 3 quarters · filed 2023-12-11
$26.90M
10-K/A · filed 2023-12-11
$29.20M
10-K · filed 2021-02-19
2020-09-30$44.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$46.50M
derived: sum of 2 quarters · filed 2021-11-05
$61.80M
10-Q · filed 2021-11-05
$64.40M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$1.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$16.90M
10-Q · filed 2021-07-30
$19.50M
derived: sum of 3 quarters · filed 2022-02-25
$11.10M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$15.30M
10-Q · filed 2021-04-30
$17.90M
derived: sum of 2 quarters · filed 2022-02-25
$9.50M
derived: sum of 3 quarters · filed 2022-02-25
$37.80M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$2.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$5.80M
derived: sum of 2 quarters · filed 2022-02-25
$22.50M
derived: sum of 3 quarters · filed 2022-02-25
$39.10M
10-K · filed 2022-02-25
$27.40M
10-K · filed 2020-02-25
2019-09-30-$8.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$19.90M
derived: sum of 2 quarters · filed 2020-11-06
$36.50M
10-Q · filed 2020-11-06
$33.40M
derived: sum of 4 quarters · filed 2021-02-19
2019-06-30$28.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$44.90M
10-Q · filed 2020-07-31
$41.80M
derived: sum of 3 quarters · filed 2021-02-19
$48.60M
derived: sum of 4 quarters · filed 2021-02-19
2019-03-31$16.60M
10-Q · filed 2020-05-01
$13.50M
derived: sum of 2 quarters · filed 2021-02-19
$20.30M
derived: sum of 3 quarters · filed 2021-02-19
$21.90M
derived: sum of 4 quarters · filed 2021-02-19
2018-12-31-$3.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$3.70M
derived: sum of 2 quarters · filed 2021-02-19
$5.30M
derived: sum of 3 quarters · filed 2021-02-19
$13.00M
10-K · filed 2021-02-19
$7.90M
10-K · filed 2019-02-22
2018-09-30$6.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$8.40M
derived: sum of 2 quarters · filed 2019-11-07
$16.10M
10-Q · filed 2019-11-07
$5.92M
10-Q · filed 2018-11-02
$17.64M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$1.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$9.30M
10-Q · filed 2019-08-02
$6.12M
10-Q · filed 2018-08-03
$10.84M
derived: sum of 3 quarters · filed 2020-02-25
$13.28M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$7.70M
10-Q · filed 2019-05-08
$7.61M
10-Q · filed 2018-05-04
$9.24M
derived: sum of 2 quarters · filed 2020-02-25
$11.68M
derived: sum of 3 quarters · filed 2020-02-25
$13.74M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$1.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$3.98M
derived: sum of 2 quarters · filed 2020-02-25
$6.04M
derived: sum of 3 quarters · filed 2020-02-25
$3.70M
10-K · filed 2020-02-25
$3.73M
10-K · filed 2018-02-23
2017-09-30$2.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$4.50M
derived: sum of 2 quarters · filed 2018-11-02
$2.16M
10-Q · filed 2018-11-02
$1.11M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$2.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
-$276.00K
10-Q · filed 2018-08-03
-$1.32M
derived: sum of 3 quarters · filed 2019-02-22
$111.00K
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31-$2.34M
10-Q · filed 2018-05-04
$2.34M
10-Q · filed 2017-05-05
-$3.38M
derived: sum of 2 quarters · filed 2019-02-22
-$1.95M
derived: sum of 3 quarters · filed 2019-02-22
$5.32M
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31-$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$387.00K
derived: sum of 2 quarters · filed 2019-02-22
$7.66M
derived: sum of 3 quarters · filed 2019-02-22
$2.10M
10-K · filed 2019-02-22
$2.09M
10-K · filed 2017-02-28
2016-09-30$1.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$8.70M
derived: sum of 2 quarters · filed 2017-11-03
$3.15M
10-Q · filed 2017-11-03
-$3.15M
10-Q · filed 2016-11-09
-$183.00K
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$7.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$1.71M
10-Q · filed 2017-08-04
-$1.62M
derived: sum of 3 quarters · filed 2018-02-23
$1.86M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31-$5.55M
10-Q · filed 2017-05-05
$5.55M
10-Q · filed 2016-05-06
-$8.88M
derived: sum of 2 quarters · filed 2018-02-23
-$5.41M
derived: sum of 3 quarters · filed 2018-02-23
-$8.12M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31-$3.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$146.00K
derived: sum of 2 quarters · filed 2018-02-23
-$2.57M
derived: sum of 3 quarters · filed 2018-02-23
-$2.32M
10-K · filed 2018-02-23
2015-09-30$3.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$761.00K
derived: sum of 2 quarters · filed 2016-11-09
$1.01M
10-Q · filed 2016-11-09
-$1.01M
10-Q · filed 2015-11-06
-$1.36M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30-$2.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
-$2.46M
10-Q · filed 2016-08-05
-$4.84M
derived: sum of 3 quarters · filed 2017-02-28
$5.44M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$249.00K
10-Q · filed 2016-05-06
-$2.12M
derived: sum of 2 quarters · filed 2017-02-28
$8.15M
derived: sum of 3 quarters · filed 2017-02-28
$9.28M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31-$2.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$7.91M
derived: sum of 2 quarters · filed 2017-02-28
$9.03M
derived: sum of 3 quarters · filed 2017-02-28
$8.47M
10-K · filed 2017-02-28
2014-09-30$10.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$11.40M
derived: sum of 2 quarters · filed 2015-11-06
$10.85M
10-Q · filed 2015-11-06
$13.54M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$1.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$567.00K
10-Q · filed 2015-08-06
$3.26M
derived: sum of 3 quarters · filed 2016-02-29
$5.06M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$556.00K
10-Q · filed 2015-05-08
$2.14M
derived: sum of 2 quarters · filed 2016-02-29
$3.94M
derived: sum of 3 quarters · filed 2016-02-29
$5.42M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$2.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$4.49M
derived: sum of 2 quarters · filed 2016-02-29
$5.98M
derived: sum of 3 quarters · filed 2016-02-29
$6.23M
10-K · filed 2016-02-29
2013-09-30$1.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$3.29M
derived: sum of 2 quarters · filed 2014-11-10
$3.53M
10-Q · filed 2014-11-10
$3.03M
derived: sum of 4 quarters · filed 2015-03-09
2013-06-30$1.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$1.73M
10-Q · filed 2014-08-08
$1.23M
derived: sum of 3 quarters · filed 2015-03-09
$3.66M
derived: sum of 4 quarters · filed 2015-03-09
2013-03-31$246.00K
10-Q · filed 2014-05-12
-$260.00K
derived: sum of 2 quarters · filed 2015-03-09
$2.17M
derived: sum of 3 quarters · filed 2015-03-09
$1.73M
derived: sum of 4 quarters · filed 2015-03-09
2012-12-31-$506.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
$1.93M
derived: sum of 2 quarters · filed 2015-03-09
$1.48M
derived: sum of 3 quarters · filed 2015-03-09
$1.04M
10-K · filed 2015-03-09
2012-09-30$2.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$1.99M
derived: sum of 2 quarters · filed 2013-11-08
$1.54M
10-Q · filed 2013-11-08
$1.02M
derived: sum of 4 quarters · filed 2014-03-10
2012-06-30-$445.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
-$888.00K
10-Q · filed 2013-08-06
-$1.42M
derived: sum of 3 quarters · filed 2014-03-10
-$147.00K
derived: sum of 4 quarters · filed 2014-03-10
2012-03-31-$443.00K
10-Q · filed 2013-05-03
-$971.00K
derived: sum of 2 quarters · filed 2014-03-10
$298.00K
derived: sum of 3 quarters · filed 2014-03-10
-$180.00K
derived: sum of 4 quarters · filed 2014-03-10
2011-12-31-$528.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10
$741.00K
derived: sum of 2 quarters · filed 2014-03-10
$263.00K
derived: sum of 3 quarters · filed 2014-03-10
-$660.00K
10-K · filed 2014-03-10
2011-09-30$1.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
$791.00K
derived: sum of 2 quarters · filed 2012-11-01
-$132.00K
10-Q · filed 2012-11-01
$270.00K
10-Q · filed 2011-11-04
$1.43M
derived: sum of 4 quarters · filed 2013-03-08
2011-06-30-$478.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
-$1.40M
10-Q · filed 2012-08-03
$1.56M
10-Q · filed 2011-08-05
$157.00K
derived: sum of 3 quarters · filed 2013-03-08
-$796.00K
derived: sum of 4 quarters · filed 2013-03-08
2011-03-31-$923.00K
10-Q · filed 2012-05-04
$635.00K
derived: sum of 2 quarters · filed 2013-03-08
-$318.00K
derived: sum of 3 quarters · filed 2013-03-08
2010-12-31$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08
$605.00K
derived: sum of 2 quarters · filed 2013-03-08
$764.00K
10-K · filed 2013-03-08
2010-09-30-$953.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
-$794.00K
10-Q · filed 2011-11-04
2010-06-30$159.00K
10-Q · filed 2011-08-05
2009-12-31$1.44M
10-K · filed 2012-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45